These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 26530718)

  • 1. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.
    Cao H; Ren M; Guo L; Shang H; Zhang J; Song Y; Wang H; Wang B; Li X; Hu J; Wang X; Wang D; Chen J; Li S; Chen L
    Trials; 2010 Mar; 11():27. PubMed ID: 20214831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
    Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
    Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lian F; Li G; Chen X; Wang X; Piao C; Wang J; Hong Y; Ba Z; Wu S; Zhou X; Lang J; Liu Y; Zhang R; Hao J; Zhu Z; Li H; Fang Liu H; Cao A; Yan Z; An Y; Bai Y; Wang Q; Zhen Z; Yu C; Wang CZ; Yuan CS; Tong X
    J Clin Endocrinol Metab; 2014 Feb; 99(2):648-55. PubMed ID: 24432995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
    Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
    BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.
    Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G
    Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Chinese herbal medicine Jinqi Jiangtang Tablet on serum matrix metalloproteinase-9 level and its expression in peripheral blood monocytes of rats with diabetes mellitus].
    Wang H; Shen L; Wang ZG; Cao Y
    Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):442-6. PubMed ID: 21486558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meta-analysis of effect of Jinqi Jiangtang Tablets on treating insulin resistance in type 2 diabetes].
    Deng ZY; Wang MJ; Fan YH; Liu M
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):188-195. PubMed ID: 32237429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
    Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
    J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
    [No Abstract]   [Full Text] [Related]  

  • 12. JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial.
    Wang H; Guo L; Shang H; Ren M; Wang X; Wang D; Chen J; Li S; Chen L; Wang Y; Liu Z; Zhai J; Song Y; Cao H; Zhang J; Liu C; Sun X; Huo D; Mu W; Zhang L; Zheng W; Yan X; Yao C
    Sci Rep; 2017 Sep; 7(1):11190. PubMed ID: 28894283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes.
    Gao H; Yang Y; Deng J; Liang J; Zhang W; Feng X
    Complement Ther Med; 2019 Dec; 47():102021. PubMed ID: 31780013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
    Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
    Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
    Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
    J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.
    Cao Y; Yao G; Sheng Y; Yang L; Wang Z; Yang Z; Zhuang P; Zhang Y
    J Diabetes Res; 2019; 2019():1872134. PubMed ID: 30733971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Chinese medicine formula (Jinqi Jiangtang Tablet): A review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications.
    Liu Y; Wang A; Wen L; Yang Z; Yang X; Zhang X; Yan D
    J Ethnopharmacol; 2019 May; 236():1-8. PubMed ID: 30802612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.
    Luo Y; Wang H; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Paul SK
    J Diabetes Res; 2022; 2022():2971382. PubMed ID: 35036447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.